Ripretinib, also known as DCC-2618, is a potent, orally active and selective KIT/PDGFR inhibitor with potential antineoplastic activity. DCC-2618 ( Ripretinib ), Bulk in stock, contact us by email for Bulk quotation. Kg scale intermediates are also be provided by custom synthesis.
Contact:Wuhan Sun-shineBio-technologyCorporation Limited Add: Building C16, No.388Gaoxin 2Road, East Lake Hi-tech Development Zone, Wuhan 430200, China Tel: +86-27-65522452 QQ:1973737790
Web:http://www.sun-shinechem.com
|